Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses
Display Omitted
Gespeichert in:
| Autor*in: |
Macho-Fernandez, Elodie [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:530 ; year:2017 ; number:1 ; day:15 ; month:09 ; pages:354-363 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2017.07.054 |
|---|
| Katalog-ID: |
ELV020285698 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV020285698 | ||
| 003 | DE-627 | ||
| 005 | 20230623154047.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2017.07.054 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000376.pica |
| 035 | |a (DE-627)ELV020285698 | ||
| 035 | |a (ELSEVIER)S0378-5173(17)30662-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Macho-Fernandez, Elodie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses |
| 264 | 1 | |c 2017 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a REV α-GalCer |2 Elsevier | |
| 650 | 7 | |a SUV α-GalCer |2 Elsevier | |
| 650 | 7 | |a α-GalCer-PEG |2 Elsevier | |
| 650 | 7 | |a m-α-GalCer |2 Elsevier | |
| 700 | 1 | |a Chekkat, Neila |4 oth | |
| 700 | 1 | |a Ehret, Christophe |4 oth | |
| 700 | 1 | |a Thomann, Jean-Sébastien |4 oth | |
| 700 | 1 | |a De Giorgi, Marcella |4 oth | |
| 700 | 1 | |a Spanedda, Maria Vittoria |4 oth | |
| 700 | 1 | |a Bourel-Bonnet, Line |4 oth | |
| 700 | 1 | |a Betbeder, Didier |4 oth | |
| 700 | 1 | |a Heurtault, Béatrice |4 oth | |
| 700 | 1 | |a Faveeuw, Christelle |4 oth | |
| 700 | 1 | |a Fournel, Sylvie |4 oth | |
| 700 | 1 | |a Frisch, Benoît |4 oth | |
| 700 | 1 | |a Trottein, François |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:530 |g year:2017 |g number:1 |g day:15 |g month:09 |g pages:354-363 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2017.07.054 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 530 |j 2017 |e 1 |b 15 |c 0915 |h 354-363 |g 10 | ||
| author_variant |
e m f emf |
|---|---|
| matchkey_str |
machofernandezelodiechekkatneilaehretchr:2017----:ouiiainfaatsleaienqeumduipcontrlilrclat |
| hierarchy_sort_str |
2017 |
| bklnumber |
44.61 |
| publishDate |
2017 |
| allfields |
10.1016/j.ijpharm.2017.07.054 doi GBV00000000000376.pica (DE-627)ELV020285698 (ELSEVIER)S0378-5173(17)30662-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Macho-Fernandez, Elodie verfasserin aut Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer Elsevier Chekkat, Neila oth Ehret, Christophe oth Thomann, Jean-Sébastien oth De Giorgi, Marcella oth Spanedda, Maria Vittoria oth Bourel-Bonnet, Line oth Betbeder, Didier oth Heurtault, Béatrice oth Faveeuw, Christelle oth Fournel, Sylvie oth Frisch, Benoît oth Trottein, François oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:530 year:2017 number:1 day:15 month:09 pages:354-363 extent:10 https://doi.org/10.1016/j.ijpharm.2017.07.054 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 530 2017 1 15 0915 354-363 10 |
| spelling |
10.1016/j.ijpharm.2017.07.054 doi GBV00000000000376.pica (DE-627)ELV020285698 (ELSEVIER)S0378-5173(17)30662-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Macho-Fernandez, Elodie verfasserin aut Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer Elsevier Chekkat, Neila oth Ehret, Christophe oth Thomann, Jean-Sébastien oth De Giorgi, Marcella oth Spanedda, Maria Vittoria oth Bourel-Bonnet, Line oth Betbeder, Didier oth Heurtault, Béatrice oth Faveeuw, Christelle oth Fournel, Sylvie oth Frisch, Benoît oth Trottein, François oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:530 year:2017 number:1 day:15 month:09 pages:354-363 extent:10 https://doi.org/10.1016/j.ijpharm.2017.07.054 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 530 2017 1 15 0915 354-363 10 |
| allfields_unstemmed |
10.1016/j.ijpharm.2017.07.054 doi GBV00000000000376.pica (DE-627)ELV020285698 (ELSEVIER)S0378-5173(17)30662-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Macho-Fernandez, Elodie verfasserin aut Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer Elsevier Chekkat, Neila oth Ehret, Christophe oth Thomann, Jean-Sébastien oth De Giorgi, Marcella oth Spanedda, Maria Vittoria oth Bourel-Bonnet, Line oth Betbeder, Didier oth Heurtault, Béatrice oth Faveeuw, Christelle oth Fournel, Sylvie oth Frisch, Benoît oth Trottein, François oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:530 year:2017 number:1 day:15 month:09 pages:354-363 extent:10 https://doi.org/10.1016/j.ijpharm.2017.07.054 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 530 2017 1 15 0915 354-363 10 |
| allfieldsGer |
10.1016/j.ijpharm.2017.07.054 doi GBV00000000000376.pica (DE-627)ELV020285698 (ELSEVIER)S0378-5173(17)30662-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Macho-Fernandez, Elodie verfasserin aut Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer Elsevier Chekkat, Neila oth Ehret, Christophe oth Thomann, Jean-Sébastien oth De Giorgi, Marcella oth Spanedda, Maria Vittoria oth Bourel-Bonnet, Line oth Betbeder, Didier oth Heurtault, Béatrice oth Faveeuw, Christelle oth Fournel, Sylvie oth Frisch, Benoît oth Trottein, François oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:530 year:2017 number:1 day:15 month:09 pages:354-363 extent:10 https://doi.org/10.1016/j.ijpharm.2017.07.054 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 530 2017 1 15 0915 354-363 10 |
| allfieldsSound |
10.1016/j.ijpharm.2017.07.054 doi GBV00000000000376.pica (DE-627)ELV020285698 (ELSEVIER)S0378-5173(17)30662-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Macho-Fernandez, Elodie verfasserin aut Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses 2017 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer Elsevier Chekkat, Neila oth Ehret, Christophe oth Thomann, Jean-Sébastien oth De Giorgi, Marcella oth Spanedda, Maria Vittoria oth Bourel-Bonnet, Line oth Betbeder, Didier oth Heurtault, Béatrice oth Faveeuw, Christelle oth Fournel, Sylvie oth Frisch, Benoît oth Trottein, François oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:530 year:2017 number:1 day:15 month:09 pages:354-363 extent:10 https://doi.org/10.1016/j.ijpharm.2017.07.054 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 530 2017 1 15 0915 354-363 10 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:530 year:2017 number:1 day:15 month:09 pages:354-363 extent:10 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:530 year:2017 number:1 day:15 month:09 pages:354-363 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
REV α-GalCer SUV α-GalCer α-GalCer-PEG m-α-GalCer |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Macho-Fernandez, Elodie @@aut@@ Chekkat, Neila @@oth@@ Ehret, Christophe @@oth@@ Thomann, Jean-Sébastien @@oth@@ De Giorgi, Marcella @@oth@@ Spanedda, Maria Vittoria @@oth@@ Bourel-Bonnet, Line @@oth@@ Betbeder, Didier @@oth@@ Heurtault, Béatrice @@oth@@ Faveeuw, Christelle @@oth@@ Fournel, Sylvie @@oth@@ Frisch, Benoît @@oth@@ Trottein, François @@oth@@ |
| publishDateDaySort_date |
2017-01-15T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV020285698 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV020285698</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623154047.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2017.07.054</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000376.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV020285698</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(17)30662-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Macho-Fernandez, Elodie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">REV α-GalCer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SUV α-GalCer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">α-GalCer-PEG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">m-α-GalCer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chekkat, Neila</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ehret, Christophe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomann, Jean-Sébastien</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Giorgi, Marcella</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spanedda, Maria Vittoria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bourel-Bonnet, Line</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Betbeder, Didier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heurtault, Béatrice</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faveeuw, Christelle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fournel, Sylvie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frisch, Benoît</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trottein, François</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:530</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:354-363</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2017.07.054</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">530</subfield><subfield code="j">2017</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">0915</subfield><subfield code="h">354-363</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| author |
Macho-Fernandez, Elodie |
| spellingShingle |
Macho-Fernandez, Elodie ddc 610 bkl 44.61 Elsevier REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses |
| authorStr |
Macho-Fernandez, Elodie |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.61 bkl Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer |
| topic_browse |
ddc 610 bkl 44.61 Elsevier REV α-GalCer Elsevier SUV α-GalCer Elsevier α-GalCer-PEG Elsevier m-α-GalCer |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n c nc c e ce j s t jst g m d gm gmd m v s mv mvs l b b lbb d b db b h bh c f cf s f sf b f bf f t ft |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses |
| ctrlnum |
(DE-627)ELV020285698 (ELSEVIER)S0378-5173(17)30662-2 |
| title_full |
Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses |
| author_sort |
Macho-Fernandez, Elodie |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
354 |
| author_browse |
Macho-Fernandez, Elodie |
| container_volume |
530 |
| physical |
10 |
| class |
610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Macho-Fernandez, Elodie |
| doi_str_mv |
10.1016/j.ijpharm.2017.07.054 |
| dewey-full |
610 |
| title_sort |
solubilization of α-galactosylceramide in aqueous medium: impact on natural killer t cell activation and antitumor responses |
| title_auth |
Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
1 |
| title_short |
Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses |
| url |
https://doi.org/10.1016/j.ijpharm.2017.07.054 |
| remote_bool |
true |
| author2 |
Chekkat, Neila Ehret, Christophe Thomann, Jean-Sébastien De Giorgi, Marcella Spanedda, Maria Vittoria Bourel-Bonnet, Line Betbeder, Didier Heurtault, Béatrice Faveeuw, Christelle Fournel, Sylvie Frisch, Benoît Trottein, François |
| author2Str |
Chekkat, Neila Ehret, Christophe Thomann, Jean-Sébastien De Giorgi, Marcella Spanedda, Maria Vittoria Bourel-Bonnet, Line Betbeder, Didier Heurtault, Béatrice Faveeuw, Christelle Fournel, Sylvie Frisch, Benoît Trottein, François |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijpharm.2017.07.054 |
| up_date |
2024-07-06T17:11:48.370Z |
| _version_ |
1803850516656029696 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV020285698</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623154047.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2017.07.054</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000376.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV020285698</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(17)30662-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Macho-Fernandez, Elodie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">REV α-GalCer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SUV α-GalCer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">α-GalCer-PEG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">m-α-GalCer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chekkat, Neila</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ehret, Christophe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomann, Jean-Sébastien</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Giorgi, Marcella</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spanedda, Maria Vittoria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bourel-Bonnet, Line</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Betbeder, Didier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heurtault, Béatrice</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faveeuw, Christelle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fournel, Sylvie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frisch, Benoît</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trottein, François</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:530</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:354-363</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2017.07.054</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">530</subfield><subfield code="j">2017</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">0915</subfield><subfield code="h">354-363</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| score |
7.3985004 |